About Averitas Pharma
Averitas Pharma is a Healthcare company based in Morristown (United States) founded in 2018, and was acquired by Gruenenthal Group in November 2018. Manufacturer of non-opioid drugs. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas. Its legal entity is Averitas Pharma, Inc.
Company details
Averitas Pharma was founded in 2018 and is based in Morristown, United States. Non-opioid drugs are manufactured by the company within the pharmaceutical sector. Operations are centered on the development and production of these medications, with a focus on alternatives to traditional pain treatments. The companys domain, averitaspharma.com, supports its activities in this field. Geographic presence is maintained primarily in the United States.
- Headquarters Morristown, United States
- Stage Acquired
- SectorsHealthcare
- Website averitaspharma.com
- Social LinkedIn
- Acquired by Gruenenthal Group (Nov 2018)
- Legal Name Averitas Pharma, Inc
- Investors
- Acquired byGruenenthal Group
(Nov 2018)
Investors in Averitas Pharma
Averitas Pharma has secured backing from 1 investor. Prominent investors backing the company include Gruenenthal Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialty biopharmaceutical products are developed internationally by Gruenenthal Group. | 1946 | grunenthal.com | Aachen, Germany |
Investor details for Averitas Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Averitas Pharma
2 dated milestones of Averitas Pharma, from founding to its latest funding, stage changes and deals.
- Founded Averitas Pharma is founded.
- Exit Acquired by Gruenenthal Group.
Web traffic of Averitas Pharma
The website of Averitas Pharma (averitaspharma.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 18.9% vs previous month
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Averitas Pharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Averitas Pharma
Averitas Pharma was founded in 2018.
Averitas Pharma is headquartered in Morristown, United States. It is registered at Morristown, New Jersey, United States.
Averitas Pharma was founded in 2018 and is based in Morristown, United States. Non-opioid drugs are manufactured by the company within the pharmaceutical sector. Operations are centered on the development and production of these medications, with a focus on alternatives to traditional pain treatments. The companys domain, averitaspharma.com, supports its activities in this field. Geographic presence is maintained primarily in the United States.
Averitas Pharma has 1 investor. Key investors include Gruenenthal Group.
Averitas Pharma operates through Averitas Pharma, Inc.
Yes. Averitas Pharma was acquired by Gruenenthal Group in November 2018.